Gene expression profiling in follicular lymphoma and its implication for clinical practice

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Follicular lymphoma (FL) is an indolent B-cell neoplasm with a relapsing course.
• Clinical outcomes in FL are increasingly linked to immune microenvironment gene signatures.
• Previous prognostic gene signatures have faced challenges in verification.

Purpose of the Study:

• To investigate immune microenvironment-associated gene expression profiles in follicular lymphoma.
• To identify gene signatures that differentiate between newly diagnosed and relapsed FL.
• To explore the role of T-cells and proliferation in FL pathogenesis.

Main Methods:

• Gene expression profiling using a custom oligonucleotide microarray on 31 FL patients (19 newly diagnosed, 12 relapsed).
• Template matching was employed to define 'T-CELL' and 'PROLIFERATION' gene sets.
• Analysis focused on identifying differential gene expression and correlating gene profiles with clinical status.

Main Results:

• Unsupervised analysis did not distinguish clinically different FL subgroups.
• Defined 'T-CELL' and 'PROLIFERATION' gene sets showed overrepresentation of functionally similar genes.
• A 'poor profile' (high PROLIFERATION/low T-CELL score) was significantly associated with relapsed FL.
• Significant differences in the T-CELL profile were observed between initial diagnosis and relapse samples.

Conclusions:

• The T-CELL and PROLIFERATION gene profiles offer insights into FL behavior.
• A 'poor profile' comprising high proliferation and low T-cell signatures is linked to relapse in FL.
• T-cell number and expression patterns are crucial in the development and progression of follicular lymphoma.